ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,450Medicare Part D Prescriptions Filled, Including Refills

Rank: 150 out of 783

$618K Total Retail Price of All Prescriptions

Rank: 193 out of 783

493 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
72% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 493 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

21% of this provider’s 493 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 8,564 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
HYDROCODONE-ACETAMINOPHEN 495 299 S3 1 2
FUROSEMIDE 427 368 2 7
LEVOTHYROXINE SODIUM 396 333 3 1
NAMENDA 356 331 4 32
LISINOPRIL 351 261 5 4
DONEPEZIL HCL 339 303 6 24
OMEPRAZOLE 294 238 7 6
SIMVASTATIN 281 220 8 3
AMLODIPINE BESYLATE 265 198 9 5
METOPROLOL TARTRATE 218 166 10 9
POTASSIUM CHLORIDE 204 178 11 16
METFORMIN HCL 193 98 12 8
CARVEDILOL 185 126 13 21
WARFARIN SODIUM 181 159 14 10
RISPERIDONE 168 151 15 67
TRAMADOL HCL 162 120 16 20
GABAPENTIN 154 104 17 15
LANTUS 137 73 18 38
FAMOTIDINE 133 80 19 55
PANTOPRAZOLE SODIUM 131 115 20 30
CITALOPRAM HBR 129 70 21 19
QUETIAPINE FUMARATE 122 85 22 79
CARBIDOPA-LEVODOPA 108 99 23 88
AZITHROMYCIN 103 71 24 41
PREDNISONE 102 69 25 36
ESCITALOPRAM OXALATE 99 88 26 54
NOVOLOG 91 53 27 81
TAMSULOSIN HCL 91 63 27 26
KLOR-CON M20 82 75 29 48
DIGOXIN 81 72 30 61
FENTANYL 81 78 S2 30 65
POLYETHYLENE GLYCOL 3350 80 77 32 43
EXELON 75 75 33 109
ISOSORBIDE MONONITRATE ER 75 64 33 40
CYMBALTA 74 23 35 35
GLIMEPIRIDE 72 70 36 34
CLONIDINE HCL 70 62 37 60
CLOPIDOGREL 69 47 38 29
SERTRALINE HCL 68 65 39 22
LYRICA 67 58 40 98
LEVOFLOXACIN 66 55 41 75
SULFAMETHOXAZOLE-TRIMETHOPRIM 63 57 42 95
BACLOFEN 62 30 43 125
AMITRIPTYLINE HCL 60 34 R 44 77
IBUPROFEN 59 39 45 115
CYCLOBENZAPRINE HCL 59 34 R 45 63
TRAZODONE HCL 58 56 47 39
NYSTATIN 58 42 47 106
LEVETIRACETAM 57 27 49 89
HYDROCHLOROTHIAZIDE 56 44 50 12
METOPROLOL SUCCINATE 56 55 50 13
DIVALPROEX SODIUM 54 52 52 72
MIRTAZAPINE 53 45 53 52
RANITIDINE HCL 51 31 54 44
ZOLPIDEM TARTRATE 51 29 54 23
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 28, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.